Contura   Report issue

Contributed to NME For profit Phase 3
Founded: London United Kingdom (1996)
Status: Acquired by Axonics (2021)

Organization Overview

First Clinical Trial
1999
NCT00841113
First Marketed Drug
2003
abarelix (plenaxis)
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Speciality European | SPECIALITY EUROPEAN